Global Autism Spectrum Disorder (ASD) Treatment Market Report, Industry Analysis and Forecast to 2029

Autism Spectrum Disorder Market is estimated to reach $5.5 billion by 2030, growing at a CAGR of 5.5% from 2023-2030. Autism spectrum disorder (ASD) is a developmental disability caused by differences in the brain. Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects social communication and interaction, as well as behavior and cognitive function. Scientists believe there are multiple causes of autism spectrum disorder (ASD) that act together to change the most common ways people develop. The autism spectrum disorder (ASD) includes multiple disorders such as autistic disorder, Asperger’s syndrome, pervasive development disorder (PDD).

The increase in the prevalence of autism spectrum disorder (ASD) and the rise in the diagnosis rate of autism spectrum disorder (ASD) drive the Autism Spectrum Disorders Market Growth.Also, the growing awareness of autism spectrum disorder (ASD) has encouraged early detection and diagnosis, therefore, permitting access to services to more children as early as possible. The augmenting number of awareness campaigns through various government initiatives across the globe has ensured the children suffering from ASD to have early access to evidence-based therapies.

Market Snapshot:

Infographics

Autism Spectrum Disorder Market - Report Coverage:

The “Autism Spectrum Disorder Market Report - Forecast (2023-2030)” by Marketlook Consulting, covers an in-depth analysis of the following segments in the Autism Spectrum Disorder   Market.

COVID-19 / Ukraine Crisis - Impact Analysis:  

• Due to the onset of the dangerous corona virus, the market disrupted and owing to the lockdown restrictions following the government directives, the therapy centres treatment the autistic disorder patents and children halted. Moreover, the R&D in this field also showcased a slowdown. However, growing anxiety level of the patients as well as their caregivers, with the fear of contracting covid-19 fall under vulnerable groups led to a strong and quick adoption of telehealth. Telehealth companies generated a positive revenue during covid. This led to bolstered prescription of antipsychotic drugs, SSRI and sleep medications. Thus, the online channel to procure drugs and consult doctor online for autism disorder contributed to the market growth during these uncertain times.

The Russia-Ukraine crisis would have a negative impact owing to the economic imbalance in the society and financial conditions of the citizens in those contries.

Key Takeaways:

North America Region Dominates the Market

Geographically, in the global autism spectrum disorder marketshare, North America is analyzed to grow with the highest CAGR of XX% during the forecast period 2023-2030. North America is anticipated to dominate the market as the rising prevalence of autism disorder across the U.S. coupled with the growing adoption and uptake in the therapies are prime growth factor for the region. More than 5 million people in the U.S. have autism spectrum disorder (ASD). Currently, around 1 in 54 children in the U.S. is autistic, as per ABA Centers of America.

Autistic Disorder to Register the Fastest Growth

Autistic Disorder accounted for the largest market share in 2022. This type is considered the most severe and common form of autism. The segment is driven by snowballing research and development as well as the initiatives undertaken by the market players and government. People with autistic disorder usually have significant language delays, social and communication challenges, and unusual behaviours and interests, and people with autistic disorder also have an intellectual disability. People who have autistic disorder are often hypersensitive and avoid contact with other people on many occasions.

Behavioural ApproachWitnessing a High Demand

Based on the treatment approach, behavioural approach accounted for the largest market share in 2022. Behaviour and communication approaches are helpful for children suffering from ASD as these can provide structure, way, and organization for the child in addition to family participation. These programs are typically highly structured and rigorous and may involve the participation of parents, siblings, and other family members. Many behavioural programs address the range of social, language, and behavioural difficulties associated with ASD.

Lack of Approved Drugs May Hamper the Market Growth

As there are no drugs as of now to treat the disorder or any of its associated symptoms despite the emanating need for effective clinical and drug trials for ASD, the market is anticipated to hamper. Moreover, no specialised doctors in this area also pose a negative threat to the market.

Autism Spectrum Disorder   Market Share (%) By Region, 2022

For More Details on This Report - Request for Sample

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Autism Spectrum Disorder   Market. The top 10 companies in this industry are listed below:

1. Johnson & Johnson Services, Inc.
2. Bristol Myers Squibb
3. Otsuka Pharmaceutical Co., Ltd.
4. Pfizer Inc.
5. Roche Group
6. Allergan
7. Merck & Co.
8. AstraZeneca
9. Novartis AG.
10. Eli Lilly and Company